News + Events

View recent news, press releases, and events

Explore by Category

Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions

April 08, 2021

Value of KidneyIntelX Testing Demonstrated by Data from 401 Physician Study Presented at National Kidney Foundation 2021 Spring Clinical Meetings NEW YORK, April 8, 2021 – Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) announces findings…

News

Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure

April 05, 2021

News

The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health

February 24, 2021

News

American Society of Nephrology and Renalytix to Co-Host Virtual Capital Markets Day for Kidney Health

February 04, 2021

News

Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics

January 14, 2021

News

Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita

January 05, 2021

News

RenalytixAI Receives California Commercial Laboratory Certification

September 22, 2020

News

RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System

September 18, 2020

News

RenalytixAI Files Submission Seeking U.S. FDA Clearance of KidneyIntelX

August 26, 2020

News

Renalytix AI and AstraZeneca Team Up to Improve Chronic Kidney Disease Outcomes

August 21, 2020